Griffon Pharmaceuticals appoints Dr. Marc Cluzel to Board of Directors
11. Dezember 2018 07:00 ET
|
Griffon Pharmaceuticals
MONTREAL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Montreal-based biopharmaceutical company Griffon Pharmaceuticals Inc. (“Griffon”) announced today that Marc Cluzel, MD, PhD, joins the company’s Board of...